Title | Type | SJR | H index | Total Docs. (2008) | Total Docs. (3years) | Total Refs. (2008) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2008) | %Female (2008) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
147 | American Journal of PharmacoGenomics | journal | 0.682 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
146 | Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry | journal | 16 | 57 | 0 | 2434 | 0 | 0 | 0.00 | 42.70 | 53.08 | ||
145 | Biomarker Insights | journal | 40 | 46 | 0 | 2862 | 0 | 0 | 0.00 | 62.22 | 34.38 | ||
144 | Biomolecules and Therapeutics | journal | 56 | 65 | 0 | 1800 | 0 | 0 | 0.00 | 27.69 | 36.36 | ||
143 | Chinese Journal of Cancer Biotherapy | journal | 5 | 129 | 0 | 2495 | 0 | 0 | 0.00 | 19.34 | 37.68 | ||
142 | Current Molecular Pharmacology | journal | 49 | 23 | 0 | 2979 | 0 | 0 | 0.00 | 129.52 | 31.08 | ||
141 | Current Pharmacogenomics and Personalized Medicine | journal | 20 | 26 | 0 | 2826 | 0 | 0 | 0.00 | 108.69 | 31.76 | ||
140 | Journal of Cardiovascular Translational Research | journal | 60 | 62 | 0 | 1486 | 0 | 0 | 0.00 | 23.97 | 23.89 | ||
139 | Methods in Pharmacology and Toxicology | book series | 14 | 22 | 0 | 1742 | 0 | 0 | 0.00 | 79.18 | 37.50 | ||
138 | Molecular Cytogenetics | journal | 38 | 2 | 0 | 69 | 0 | 0 | 0.00 | 34.50 | 50.00 | ||
137 | Molecular Medicine Reports | journal | 86 | 141 | 0 | 4799 | 0 | 0 | 0.00 | 34.04 | 31.77 | ||
136 | Bollettino Chimico Farmaceutico | journal | 0.107 Q4 | 27 | 0 | 7 | 0 | 0 | 3 | 0.00 | 0.00 | 0.00 | |
135 | Gene Therapy and Regulation | journal | 0.255 Q4 | 7 | 0 | 6 | 0 | 4 | 5 | 0.67 | 0.00 | 0.00 | |
134 | BMC Chemical Biology | journal | 1.042 Q2 | 21 | 3 | 8 | 101 | 23 | 8 | 3.20 | 33.67 | 50.00 | |
133 | Progress in Medicinal Chemistry | journal | 1.350 Q2 | 38 | 8 | 21 | 1130 | 66 | 18 | 2.08 | 141.25 | 0.00 | |
132 | Clinical Proteomics | journal | 0.185 Q4 | 42 | 12 | 21 | 596 | 7 | 19 | 0.33 | 49.67 | 24.53 | |
131 | Molecular Oncology | journal | 1.206 Q2 | 113 | 49 | 38 | 1467 | 49 | 23 | 1.29 | 29.94 | 34.52 | |
130 | Genetic Vaccines and Therapy | journal | 0.469 Q3 | 30 | 16 | 24 | 503 | 48 | 24 | 2.19 | 31.44 | 40.74 | |
129 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.139 Q4 | 29 | 3 | 29 | 313 | 5 | 24 | 0.00 | 104.33 | 0.00 | |
128 | Frontiers in Medicinal Chemistry | book series | 0.189 Q4 | 7 | 0 | 27 | 0 | 8 | 26 | 0.30 | 0.00 | 0.00 | |
127 | Progress in Molecular Biology and Translational Science | journal | 3.619 Q1 | 113 | 26 | 29 | 3763 | 145 | 29 | 3.83 | 144.73 | 25.00 | |
126 | Turkish Journal of Pharmaceutical Sciences | journal | 0.130 Q4 | 22 | 19 | 30 | 428 | 5 | 30 | 0.17 | 22.53 | 56.45 | |
125 | Journal of Nanobiotechnology | journal | 1.400 Q2 | 109 | 14 | 34 | 457 | 165 | 32 | 4.12 | 32.64 | 34.48 | |
124 | Research Communications in Molecular Pathology and Pharmacology | journal | 0.131 Q4 | 40 | 0 | 32 | 0 | 7 | 32 | 0.39 | 0.00 | 0.00 | |
123 | Progress in Drug Research | book series | 0.453 Q3 | 46 | 20 | 36 | 2384 | 58 | 33 | 2.85 | 119.20 | 25.53 | |
122 | Drugs under Experimental and Clinical Research | journal | 0.335 Q4 | 41 | 0 | 36 | 0 | 64 | 36 | 0.00 | 0.00 | 0.00 | |
121 | Frontiers in Drug Design and Discovery | book series | 0.362 Q4 | 9 | 0 | 41 | 0 | 27 | 39 | 0.66 | 0.00 | 0.00 | |
120 | Journal of Stem Cells | journal | 0.133 Q4 | 21 | 19 | 42 | 1072 | 8 | 41 | 0.19 | 56.42 | 38.46 | |
119 | Human Genomics | journal | 1.272 Q2 | 68 | 10 | 55 | 137 | 145 | 43 | 1.88 | 13.70 | 46.43 | |
118 | Drugs in Context | journal | 0.101 Q4 | 36 | 20 | 59 | 710 | 1 | 44 | 0.02 | 35.50 | 28.57 | |
117 | Pteridines | journal | 0.209 Q4 | 19 | 13 | 48 | 404 | 19 | 45 | 0.49 | 31.08 | 44.07 | |
116 | Medicinal Chemistry Reviews - Online | journal | 0.171 Q4 | 7 | 0 | 46 | 0 | 19 | 46 | 0.00 | 0.00 | 0.00 | |
115 | Current Computer-Aided Drug Design | journal | 0.361 Q4 | 32 | 30 | 52 | 2612 | 63 | 48 | 1.21 | 87.07 | 24.51 | |
114 | Drug Design Reviews Online | journal | 0.183 Q4 | 11 | 0 | 48 | 0 | 24 | 48 | 0.00 | 0.00 | 0.00 | |
113 | Expert Opinion on Medical Diagnostics | journal | 0.120 Q4 | 28 | 110 | 48 | 10164 | 9 | 48 | 0.19 | 92.40 | 31.00 | |
112 | Bioinspiration and Biomimetics | journal | 0.635 Q3 | 87 | 35 | 55 | 1108 | 146 | 53 | 2.65 | 31.66 | 16.13 | |
111 | Current Enzyme Inhibition | journal | 0.267 Q4 | 19 | 20 | 54 | 1890 | 42 | 54 | 0.78 | 94.50 | 30.91 | |
110 | Current Cancer Therapy Reviews | journal | 0.169 Q4 | 17 | 38 | 62 | 3213 | 15 | 60 | 0.24 | 84.55 | 45.05 | |
109 | Current Pharmaceutical Analysis | journal | 0.420 Q3 | 27 | 27 | 60 | 2132 | 68 | 60 | 1.13 | 78.96 | 49.52 | |
108 | Gene Therapy and Molecular Biology | journal | 0.221 Q4 | 18 | 38 | 62 | 2300 | 47 | 62 | 0.76 | 60.53 | 35.59 | |
107 | Advances in Biological Regulation | journal | 1.285 Q2 | 69 | 22 | 66 | 1316 | 161 | 63 | 2.89 | 59.82 | 37.93 | |
106 | AIDS Research and Therapy | journal | 0.649 Q3 | 49 | 26 | 68 | 938 | 153 | 68 | 2.20 | 36.08 | 48.55 | |
105 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.261 Q4 | 39 | 30 | 77 | 3787 | 53 | 75 | 0.56 | 126.23 | 42.11 | |
104 | Molecular Aspects of Medicine | journal | 2.790 Q1 | 159 | 31 | 81 | 2651 | 659 | 75 | 7.36 | 85.52 | 39.08 | |
103 | Pharmacological Reviews | journal | 10.461 Q1 | 254 | 18 | 83 | 7023 | 1906 | 79 | 21.77 | 390.17 | 24.56 | |
102 | Cell Stem Cell | journal | 10.042 Q1 | 305 | 180 | 93 | 5761 | 819 | 80 | 8.81 | 32.01 | 34.23 | |
101 | Personalized Medicine | journal | 0.252 Q4 | 36 | 79 | 94 | 2405 | 65 | 81 | 0.69 | 30.44 | 35.00 | |
100 | Medicinal Research Reviews | journal | 2.488 Q1 | 150 | 31 | 83 | 5055 | 673 | 83 | 8.81 | 163.06 | 36.56 | |
99 | Cellular Oncology | journal | 1.586 Q2 | 44 | 39 | 112 | 1025 | 298 | 85 | 2.82 | 26.28 | 41.67 | |
98 | Infectious Disorders - Drug Targets | journal | 1.121 Q2 | 61 | 34 | 93 | 2979 | 279 | 86 | 3.29 | 87.62 | 45.78 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®